Search

The main idea of a session-based recommendation system is to model the user’s historical click sequence and then summarize user preferences and predict the items the user will interact with. The session recommendation model based on graph neural networks has attracted much attention in recent years because it can accurately obtain the local relationship between items. However, the traditional session recommendation model based on graph neural Networks lack the use of user’s higher-order features or fail to address the impact of item position information on the current session, which are both critical to the recommendation system. In addition, some models proposed the position information while neglects the click frequency information. We propose a graph network recommendation model called GPAN based on position attention in response to the abovementioned problems. Specifically, we propose a novel high-low order session perceptron that uses the perceptron to model undirected and directed graphs separately to obtain high and low order item representations in a session. For position information, we designed a position layer to calculate independently. Finally, the user’s short-term preference and long-term preference are aggregated to obtain the recommendation sequence. The results through a large number of experiments on three real datasets show that the performance of the proposed GPAN model is the best.

Abstract In the development of high‐performance organic thermoelectric devices, n‐type materials, especially with small molecule semiconductors, lags far behind p‐type materials. In this paper, three small molecules are synthesized based on electron‐deficient naphthalene bis‐isatin building blocks bearing different alkyl chains with the terminal functionalized with 3‐ethylrhodanine unit and studied their aggregation and doping mechanism in detail. It is found that crystallinity plays an essential role in tuning the doping behavior of small molecules. Molecules with too strong crystallinity tend to aggregate with each other to form large crystalline domains, which cause significant performance degradation. While molecules with weak crystallinity can tolerate more dopants, most of them exhibit low mobility. By tuning the crystallinity carefully, organic thermoelectric devices based on C12NR can maintain high mobility and realize effective doping simultaneously, and a high power factor of 1.07 µW m−1 K−2 at 100 °C is realized. This delicate molecular design by modulating crystallinity provides a new avenue for realizing high‐performance organic thermoelectric devices.

Docetaxel (DTX) is one of the most promising chemotherapeutic agents for a variety of solid tumors. However, the clinical efficacy of the marketed formulation, Taxotere®, is limited due to its poor aqueous solubility, side effects caused by the emulsifier, and low selective DTX distribution in vivo. Here a facile, well-defined, and easy-to-scale up DTX-loaded N-(tert-butoxycarbonyl)-L-phenylalanine end-capped methoxy-poly(ethylene glycol)-block-poly(D,L-lactide) (mPEG-b-PLA-Phe(Boc)) micelles (DTX-PMs) were prepared in an effort to develop a less toxic and more efficacious docetaxel formulation. The physicochemical properties, pharmacokinetics, biodistribution, and in vivo anti-tumor efficacy were evaluated in comparison to the marketed DTX formulation Taxotere®. DTX was successfully encapsulated in the hydrophobic micellar core with a high encapsulation efficiency (> 95%) and a high drug loading capacity (4.81 ± 0.08%). DTX-PMs exhibited outstanding stability in the aqueous environment due to the strong interactions between the terminal amino acid residues and docetaxel. The pharmacokinetic study in Sprague–Dawley rats revealed higher DTX concentrations in both whole blood and plasma for the group treated with DTX-PMs than that treated with Taxotere® due to the improved stability of the micellar formulation. In human non-small cell lung cancer (A549) tumor-bearing Balb/c nude mice, DTX-PMs significantly improved DTX accumulation and stalled DTX elimination in tumors than in bone marrow. Furthermore, only by half of the DTX dosage, our DTX/mPEG-b-PLA-Phe(Boc) micelles can achieve similar therapeutic effects as Taxotere®. Altogether, DTX-PMs hold great promise as a simple and effective drug delivery system for cancer chemotherapy.

Organic electrochemical transistor (OECT)-based inverter introduces new prospects for energy-efficient brain-inspired artificial intelligence devices. Here, we report single-component OECT-based inverters by incorporating ambipolar p(gDPP-V). Notably, p(gDPP-V) shows state-of-the-art ambipolar OECT performances in both conventional (p/n-type mode transconductance of 29/25 S cm-1) and vertical (transconductance of 297.2/292.4 μS μm-2 under p/n operation) device architectures. Especially, the resulting highly stable vertical OECT-based inverter shows a high voltage gain of 105 V V-1 under a low driving voltage of 0.8 V. The inverter exhibits undiscovered voltage-regulated dual mode: volatile receptor and nonvolatile synapse. Moreover, applications of physiology signal recording and demonstrations of NAND/NOR logic circuits are investigated within the volatile feature, while neuromorphic simulations with a convolutional neural network and image memorizing capabilities are explored under the nonvolatile behavior. The ambipolar OECT-based inverter, capable of both volatile and nonvolatile operations, provides possibilities for the applications of reconfigurable complementary logic circuits in novel neuromorphic computing paradigms. [ABSTRACT FROM AUTHOR]

In the development of high‐performance organic thermoelectric devices, n‐type materials, especially with small molecule semiconductors, lags far behind p‐type materials. In this paper, three small molecules are synthesized based on electron‐deficient naphthalene bis‐isatin building blocks bearing different alkyl chains with the terminal functionalized with 3‐ethylrhodanine unit and studied their aggregation and doping mechanism in detail. It is found that crystallinity plays an essential role in tuning the doping behavior of small molecules. Molecules with too strong crystallinity tend to aggregate with each other to form large crystalline domains, which cause significant performance degradation. While molecules with weak crystallinity can tolerate more dopants, most of them exhibit low mobility. By tuning the crystallinity carefully, organic thermoelectric devices based on C12NR can maintain high mobility and realize effective doping simultaneously, and a high power factor of 1.07 µW m−1 K−2 at 100 °C is realized. This delicate molecular design by modulating crystallinity provides a new avenue for realizing high‐performance organic thermoelectric devices. [ABSTRACT FROM AUTHOR]

Docetaxel (DTX) is one of the most promising chemotherapeutic agents for a variety of solid tumors. However, the clinical efficacy of the marketed formulation, Taxotere®, is limited due to its poor aqueous solubility, side effects caused by the emulsifier, and low selective DTX distribution in vivo. Here a facile, well-defined, and easy-to-scale up DTX-loaded N-(tert-butoxycarbonyl)-L-phenylalanine end-capped methoxy-poly(ethylene glycol)-block-poly(D,L-lactide) (mPEG-b-PLA-Phe(Boc)) micelles (DTX-PMs) were prepared in an effort to develop a less toxic and more efficacious docetaxel formulation. The physicochemical properties, pharmacokinetics, biodistribution, and in vivo anti-tumor efficacy were evaluated in comparison to the marketed DTX formulation Taxotere®. DTX was successfully encapsulated in the hydrophobic micellar core with a high encapsulation efficiency (> 95%) and a high drug loading capacity (4.81 ± 0.08%). DTX-PMs exhibited outstanding stability in the aqueous environment due to the strong interactions between the terminal amino acid residues and docetaxel. The pharmacokinetic study in Sprague–Dawley rats revealed higher DTX concentrations in both whole blood and plasma for the group treated with DTX-PMs than that treated with Taxotere® due to the improved stability of the micellar formulation. In human non-small cell lung cancer (A549) tumor-bearing Balb/c nude mice, DTX-PMs significantly improved DTX accumulation and stalled DTX elimination in tumors than in bone marrow. Furthermore, only by half of the DTX dosage, our DTX/mPEG-b-PLA-Phe(Boc) micelles can achieve similar therapeutic effects as Taxotere®. Altogether, DTX-PMs hold great promise as a simple and effective drug delivery system for cancer chemotherapy. [ABSTRACT FROM AUTHOR]